Activation of EGFR and c-Met Signaling Pathways in Well-Differentiated Neuroendocrine Tumors of the Small Intestine
Publication
, Conference
Liu, E; Mikhitarian, K; Revetta, F; Shi, C
Published in: PANCREAS
March 1, 2013
Duke Scholars
Published In
PANCREAS
ISSN
0885-3177
Publication Date
March 1, 2013
Volume
42
Issue
2
Start / End Page
377 / 378
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Gastroenterology & Hepatology
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Liu, E., Mikhitarian, K., Revetta, F., & Shi, C. (2013). Activation of EGFR and c-Met Signaling Pathways in Well-Differentiated Neuroendocrine Tumors of the Small Intestine. In PANCREAS (Vol. 42, pp. 377–378). LIPPINCOTT WILLIAMS & WILKINS.
Liu, E., K. Mikhitarian, F. Revetta, and C. Shi. “Activation of EGFR and c-Met Signaling Pathways in Well-Differentiated Neuroendocrine Tumors of the Small Intestine.” In PANCREAS, 42:377–78. LIPPINCOTT WILLIAMS & WILKINS, 2013.
Liu E, Mikhitarian K, Revetta F, Shi C. Activation of EGFR and c-Met Signaling Pathways in Well-Differentiated Neuroendocrine Tumors of the Small Intestine. In: PANCREAS. LIPPINCOTT WILLIAMS & WILKINS; 2013. p. 377–8.
Liu, E., et al. “Activation of EGFR and c-Met Signaling Pathways in Well-Differentiated Neuroendocrine Tumors of the Small Intestine.” PANCREAS, vol. 42, no. 2, LIPPINCOTT WILLIAMS & WILKINS, 2013, pp. 377–78.
Liu E, Mikhitarian K, Revetta F, Shi C. Activation of EGFR and c-Met Signaling Pathways in Well-Differentiated Neuroendocrine Tumors of the Small Intestine. PANCREAS. LIPPINCOTT WILLIAMS & WILKINS; 2013. p. 377–378.
Published In
PANCREAS
ISSN
0885-3177
Publication Date
March 1, 2013
Volume
42
Issue
2
Start / End Page
377 / 378
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Gastroenterology & Hepatology
- 3202 Clinical sciences
- 1103 Clinical Sciences